Researcher.Life Logo

Cancer Cell International : Impact Factor & More

eISSN: 1475-2867pISSN: 1475-2867
JournalOpen Access

Key Metrics

CiteScore
6.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q3Genetics
SNIP
1.07
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Cell International

Cancer Cell International Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 2090
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Cancer Cell International ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Cell International

Diagnostic and therapeutic potential of exosomal circRNAs in cancer: decoding the circular code toward precision medicine.
  • 27 Nov 2025
  • Cancer cell international
The CCAT2 enigma: pioneering insights into colorectal cancer pathophysiology and therapeutic innovation
  • 27 Nov 2025
  • Cancer Cell International
Rubidium chloride induces ferroptosis in glioblastoma cells by disrupting glutathione metabolism and redox homeostasis.
  • 27 Nov 2025
  • Cancer cell international
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy.
  • 26 Nov 2025
  • Cancer cell international
Icariin-curcumol inhibits histone H3K18 lactylation and FOXM1 expression to enhance the sensitivity of prostate cancer cells to docetaxel
  • 25 Nov 2025
  • Cancer Cell International
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma.
  • 25 Nov 2025
  • Cancer cell international
Diagnostic and therapeutic potential of exosomal circRNAs in cancer: decoding the circular code toward precision medicine.
  • 27 Nov 2025
  • Cancer cell international
The CCAT2 enigma: pioneering insights into colorectal cancer pathophysiology and therapeutic innovation
  • 27 Nov 2025
  • Cancer Cell International
Rubidium chloride induces ferroptosis in glioblastoma cells by disrupting glutathione metabolism and redox homeostasis.
  • 27 Nov 2025
  • Cancer cell international
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy.
  • 26 Nov 2025
  • Cancer cell international
Icariin-curcumol inhibits histone H3K18 lactylation and FOXM1 expression to enhance the sensitivity of prostate cancer cells to docetaxel
  • 25 Nov 2025
  • Cancer Cell International
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma.
  • 25 Nov 2025
  • Cancer cell international

FAQs on Cancer Cell International